质粒
遗传增强
DNA
生物
计算生物学
基因
核糖核酸
遗传学
作者
Yun Liu,Sara Musetti,Leaf Huang
出处
期刊:Burger's Medicinal Chemistry and Drug Discovery
日期:2021-04-26
卷期号:: 1-35
标识
DOI:10.1002/0471266949.bmc073.pub3
摘要
Abstract Recent advances in the study of human genomics have revealed the relationship between somatic aberrations and cancer. Therapeutic genetic manipulation for cancer therapy can be achieved through treatment regimens that include gene therapy. Messenger RNA and plasmid DNA are widely applied in gene therapy. Messenger RNA therapy has received much attention in the past 10 years. In this article, we first compare messenger RNA therapeutics with plasmid DNA therapeutics and go on to list the limitations of messenger RNA therapy and advantages of plasmid DNA therapeutics. To address the unresolved challenges for plasmid DNA for further translational application, this article describes the present clinical usage of plasmid DNA, reviews the current physical and chemical delivery system proposed for nonviral plasmid DNA therapy, discusses targeted delivery strategies and specific formulation designs with promising outcomes in preclinical studies, and provides future perspectives for plasmid DNA therapy development.
科研通智能强力驱动
Strongly Powered by AbleSci AI